Merck & Co., Inc. is 1.4x more valuable than Novo Nordisk A/S by market capitalization ($293.16 B vs $202.94 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NVO | MRK |
|---|---|---|
| Market cap | $202.94 B | $293.16 B |
| US-listed rank | #67 | #44 |
| Revenue (latest FY) | - | $65.01B |
| Net income (latest FY) | - | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 998 | 996 |
Merck & Co., Inc. is 1.4x more valuable than Novo Nordisk A/S by market capitalization ($293.16 B vs $202.94 B).
Full pages: Novo Nordisk A/S and Merck & Co., Inc., or browse the full rankings.